Oncocross Co., Ltd. (KOSDAQ:382150)
South Korea flag South Korea · Delayed Price · Currency is KRW
9,330.00
+220.00 (2.41%)
Aug 14, 2025, 3:30 PM KST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022
Period Ending
Dec '24 Dec '23 Dec '22
Drugs
1.07B
Log In
Log In
Drugs Growth
1071.49%
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022
Period Ending
Dec '24 Dec '23 Dec '22
South Korea
1.07B
Log In
Log In
South Korea Growth
1071.49%
Log In
Log In